Tapewire

Nasdaq · USD

ATYR

aTYR PHARMA INC

Export transactions ↓
Tapewire entity
7233
SEC CIK
0001339970
Parsed reports
205

Last 12 months

Inside the activity.

1 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202603
Mar 202600
Apr 202600
May 202610
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 22, 2024 Filed May 23, 2024 23:16 UTC GrantStock Option (right to buy) · Derivative 24,000 $0.00 Strike: $1.86 $0.00
Disclosure

SEC source: 0000950170-24-064218 · ownership.xml · derivative · entry 1

SCHIMMEL PAUL · CIK 0001236447 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2034-05-22

F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

Read SEC document
May 22, 2024 Filed May 23, 2024 19:30 UTC GrantStock Option (right to buy) · Derivative 24,000 $0.00 Strike: $1.86 $0.00
Disclosure

SEC source: 0000950170-24-064235 · ownership.xml · derivative · entry 1

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2034-05-22

F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

Read SEC document
May 22, 2024 Filed May 23, 2024 23:19 UTC GrantStock Option (right to buy) · Derivative 24,000 $0.00 Strike: $1.86 $0.00
Disclosure

SEC source: 0000950170-24-064225 · ownership.xml · derivative · entry 1

Lucas Svetlana · CIK 0001781292 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2034-05-22

F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

Read SEC document
May 22, 2024 Filed May 23, 2024 23:07 UTC GrantStock Option (right to buy) · Derivative 24,000 $0.00 Strike: $1.86 $0.00
Disclosure

SEC source: 0000950170-24-064199 · ownership.xml · derivative · entry 1

COUGHLIN TIMOTHY · CIK 0001376043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2034-05-22

F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

Read SEC document
February 06, 2024 Filed Feb 7, 2024 01:18 UTC
Broadfoot Jill MarieChief Financial Officer
SaleCommon stock 1,590 $1.69 $2,687.10
Disclosure

SEC source: 0001209191-24-002947 · doc4.xml · nonDerivative · entry 2

Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,821

F3 · kind: Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 3, 2022.

Read SEC document
February 05, 2024 Filed Feb 6, 2024 20:20 UTC
Shukla SanjayDirector · President and CEO
Exercise / conversionRestricted Stock Unit · Derivative 10,375 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-002949 · doc4.xml · derivative · entry 2

Shukla Sanjay · CIK 0001671026 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,750

Underlying: Common Stock · 10,375 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.

F3 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.

Read SEC document
February 05, 2024 Filed Feb 6, 2024 20:20 UTC
Shukla SanjayDirector · President and CEO
Exercise / conversionCommon stock 10,375 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-002949 · doc4.xml · nonDerivative · entry 1

Shukla Sanjay · CIK 0001671026 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,548

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 05, 2024 Filed Feb 7, 2024 01:18 UTC
Broadfoot Jill MarieChief Financial Officer
Exercise / conversionRestricted Stock Unit · Derivative 3,750 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-002947 · doc4.xml · derivative · entry 3

Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 3,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.

F4 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.

Read SEC document
February 05, 2024 Filed Feb 7, 2024 01:18 UTC
Broadfoot Jill MarieChief Financial Officer
Exercise / conversionCommon stock 3,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-002947 · doc4.xml · nonDerivative · entry 1

Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,411

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 05, 2024 Filed Feb 7, 2024 01:15 UTC
DENYES NANCYGeneral Counsel
Exercise / conversionRestricted Stock Unit · Derivative 2,688 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-002945 · doc4.xml · derivative · entry 2

DENYES NANCY · CIK 0001640869 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,374

Underlying: Common Stock · 2,688 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.

F3 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.

Read SEC document
February 05, 2024 Filed Feb 7, 2024 01:15 UTC
DENYES NANCYGeneral Counsel
Exercise / conversionCommon stock 2,688 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-002945 · doc4.xml · nonDerivative · entry 1

DENYES NANCY · CIK 0001640869 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,767

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 19:35 UTC
Shukla SanjayDirector · President and CEO
GrantEmployee Stock Option (right to buy) · Derivative 600,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0001209191-24-001302 · doc4.xml · derivative · entry 1

Shukla Sanjay · CIK 0001671026 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common Stock · 600,000 shares

Expires 2034-01-05

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning February 5, 2024, such that this option will be fully exercisable on January 5, 2028. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.

Read SEC document
January 05, 2024 Filed Jan 10, 2024 00:33 UTC
Broadfoot Jill MarieChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 150,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0001209191-24-001299 · doc4.xml · derivative · entry 2

Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2034-01-05

F2 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning February 5, 2024, such that this option will be fully exercisable on January 5, 2028. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.

Read SEC document
January 05, 2024 Filed Jan 10, 2024 00:30 UTC
DENYES NANCYGeneral Counsel
GrantEmployee Stock Option (right to buy) · Derivative 150,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0001209191-24-001297 · doc4.xml · derivative · entry 2

DENYES NANCY · CIK 0001640869 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2034-01-05

F2 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning February 5, 2024, such that this option will be fully exercisable on January 5, 2028. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.

Read SEC document
December 12, 2023 Filed Dec 12, 2023 18:50 UTC
Shukla SanjayDirector · President and CEO
PurchaseCommon Stock 12,000 $1.18 $14,136.00
Disclosure

SEC source: 0001209191-23-058377 · doc4.xml · nonDerivative · entry 2

Shukla Sanjay · CIK 0001671026 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,173

F1 · price: Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.175 to $1.18 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.

Read SEC document
December 11, 2023 Filed Dec 12, 2023 18:50 UTC
Shukla SanjayDirector · President and CEO
PurchaseCommon Stock 3,000 $1.17 $3,510.00
Disclosure

SEC source: 0001209191-23-058377 · doc4.xml · nonDerivative · entry 1

Shukla Sanjay · CIK 0001671026 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,173

Read SEC document
November 13, 2023 Filed Nov 13, 2023 16:11 UTC
Shukla SanjayDirector · President and CEO
PurchaseCommon Stock 13,578 $1.11 $15,085.16
Disclosure

SEC source: 0001209191-23-054976 · doc4.xml · nonDerivative · entry 2

Shukla Sanjay · CIK 0001671026 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,173

F2 · price: Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.09 to $1.13 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.

Read SEC document
November 10, 2023 Filed Nov 13, 2023 16:11 UTC
Shukla SanjayDirector · President and CEO
PurchaseCommon Stock 1,422 $1.14 $1,618.24
Disclosure

SEC source: 0001209191-23-054976 · doc4.xml · nonDerivative · entry 1

Shukla Sanjay · CIK 0001671026 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,595

F1 · price: Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.13 to $1.14 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.

Read SEC document
July 28, 2023 Filed Aug 1, 2023 16:07 UTC
Shukla SanjayDirector · President and CEO
PurchaseCommon Stock 15,000 $2.01 $30,223.50
Disclosure

SEC source: 0001209191-23-043943 · doc4.xml · nonDerivative · entry 1

Shukla Sanjay · CIK 0001671026 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,173

F1 · price: Represents weighted average price for the shares. The shares were purchased at prices ranging from $2.01 to $2.02 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price

Read SEC document
May 17, 2023 Filed May 19, 2023 20:29 UTC
Gross Jane ADirector
GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $2.52 $0.00
Disclosure

SEC source: 0001209191-23-031012 · doc4.xml · derivative · entry 1

Gross Jane A · CIK 0001684258 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2033-05-17

F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:33 UTC
Zaknoen SaraDirector
GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $2.52 $0.00
Disclosure

SEC source: 0001209191-23-031024 · doc4.xml · derivative · entry 1

Zaknoen Sara · CIK 0001602225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2033-05-17

F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:32 UTC GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $2.52 $0.00
Disclosure

SEC source: 0001209191-23-031020 · doc4.xml · derivative · entry 1

SCHIMMEL PAUL · CIK 0001236447 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2033-05-17

F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

Read SEC document
May 17, 2023 Filed May 19, 2023 16:23 UTC GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $2.52 $0.00
Disclosure

SEC source: 0001209191-23-031002 · doc4.xml · derivative · entry 1

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2033-05-17

F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:27 UTC GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $2.52 $0.00
Disclosure

SEC source: 0001209191-23-031008 · doc4.xml · derivative · entry 3

COUGHLIN TIMOTHY · CIK 0001376043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2033-05-17

F2 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:27 UTC GiftCommon Stock 6,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-031008 · doc4.xml · nonDerivative · entry 2

COUGHLIN TIMOTHY · CIK 0001376043 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 6,000

F1 · ownership.nature: These shares are owned by the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person and his spouse serve as co-trustees of the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person may be deemed to be the beneficial owner of the securities held by the Coughlin Family Trust u/a DTD 12/07/2006.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:27 UTC GiftCommon Stock 6,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-031008 · doc4.xml · nonDerivative · entry 1

COUGHLIN TIMOTHY · CIK 0001376043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
May 17, 2023 Filed May 19, 2023 20:30 UTC GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $2.52 $0.00
Disclosure

SEC source: 0001209191-23-031016 · doc4.xml · derivative · entry 1

Lucas Svetlana · CIK 0001781292 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2033-05-17

F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

Read SEC document
May 10, 2023 Filed May 11, 2023 13:00 UTC PurchaseCommon Stock 200,000 $2.25 $450,000.00
Disclosure

SEC source: 0001209191-23-028607 · doc4.xml · nonDerivative · entry 1

SCHIMMEL PAUL · CIK 0001236447 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 313,023

F1 · price: Represents weighted average price for the shares. The shares were purchased ranging from $2.245 to $2.25 per share under the issuer's "at-the-market" offering program implemented pursuant to the issuer's Open Market Sale Agreement with Jefferies LLC. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.

F2 · ownership.nature: These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel.

Read SEC document
April 26, 2023 Filed Apr 28, 2023 20:52 UTC
Gross Jane ADirector
Exercise / conversionRestricted Stock Unit · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-026064 · doc4.xml · derivative · entry 2

Gross Jane A · CIK 0001684258 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The RSUs fully vested one year from the grant date which was April 26, 2022.

F3 · derivative.expiration_date: The RSUs fully vested one year from the grant date which was April 26, 2022.

Read SEC document
April 26, 2023 Filed Apr 28, 2023 20:52 UTC
Gross Jane ADirector
Exercise / conversionCommon stock 6,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-026064 · doc4.xml · nonDerivative · entry 1

Gross Jane A · CIK 0001684258 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022.

F2 · price: RSUs convert into common stock on a one-for-one basis.

Read SEC document
April 26, 2023 Filed Apr 28, 2023 20:56 UTC
Zaknoen SaraDirector
Exercise / conversionRestricted Stock Unit · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-026070 · doc4.xml · derivative · entry 2

Zaknoen Sara · CIK 0001602225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The RSUs fully vested one year from the grant date which was April 26, 2022.

F3 · derivative.expiration_date: The RSUs fully vested one year from the grant date which was April 26, 2022.

Read SEC document
April 26, 2023 Filed Apr 28, 2023 20:56 UTC
Zaknoen SaraDirector
Exercise / conversionCommon stock 6,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-026070 · doc4.xml · nonDerivative · entry 1

Zaknoen Sara · CIK 0001602225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022.

F2 · price: RSUs convert into common stock on a one-for-one basis.

Read SEC document
April 26, 2023 Filed Apr 28, 2023 20:54 UTC Exercise / conversionRestricted Stock Unit · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-026067 · doc4.xml · derivative · entry 4

SCHIMMEL PAUL · CIK 0001236447 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: The RSUs fully vested one year from the grant date which was April 26, 2022.

F5 · derivative.expiration_date: The RSUs fully vested one year from the grant date which was April 26, 2022.

Read SEC document
April 26, 2023 Filed Apr 28, 2023 20:54 UTC Exercise / conversionCommon stock 6,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-026067 · doc4.xml · nonDerivative · entry 1

SCHIMMEL PAUL · CIK 0001236447 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,890

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022.

F2 · price: RSUs convert into common stock on a one-for-one basis.

Read SEC document
April 26, 2023 Filed Apr 28, 2023 16:54 UTC Exercise / conversionRestricted Stock Unit · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-026069 · doc4.xml · derivative · entry 2

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 0 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The RSUs fully vested one year from the grant date which was April 26, 2022.

F4 · derivative.expiration_date: The RSUs fully vested one year from the grant date which was April 26, 2022.

Read SEC document
April 26, 2023 Filed Apr 28, 2023 16:54 UTC Exercise / conversionCommon Stock 6,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-026069 · doc4.xml · nonDerivative · entry 1

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,797

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022.

F2 · price: RSUs convert into common stock on a one-for-one basis.

F3 · balance_after: Includes 6,305 shares received as a pro-rata distribution on September 28, 2021 (the "Liquidating Distribution") from CHP II, L.P., in which the Reporting Person is a managing partner. In prior reports, the reporting person reported beneficial ownership of 108,083 shares of aTyr Pharma common stock held by CHP II, L.P., which are no longer held as of September 28, 2021 due to the Liquidating Distribution.

Read SEC document
April 26, 2023 Filed Apr 28, 2023 20:53 UTC Exercise / conversionRestricted Stock Unit · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-026065 · doc4.xml · derivative · entry 2

Lucas Svetlana · CIK 0001781292 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The RSUs fully vested one year from the grant date which was April 26, 2022.

F3 · derivative.expiration_date: The RSUs fully vested one year from the grant date which was April 26, 2022.

Read SEC document
April 26, 2023 Filed Apr 28, 2023 20:53 UTC Exercise / conversionCommon stock 6,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-026065 · doc4.xml · nonDerivative · entry 1

Lucas Svetlana · CIK 0001781292 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022.

F2 · price: RSUs convert into common stock on a one-for-one basis.

Read SEC document
April 26, 2023 Filed Apr 28, 2023 20:51 UTC Exercise / conversionRestricted Stock Unit · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-026062 · doc4.xml · derivative · entry 2

COUGHLIN TIMOTHY · CIK 0001376043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The RSUs fully vested one year from the grant date which was April 26, 2022.

F3 · derivative.expiration_date: The RSUs fully vested one year from the grant date which was April 26, 2022.

Read SEC document
April 26, 2023 Filed Apr 28, 2023 20:51 UTC Exercise / conversionCommon stock 6,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-026062 · doc4.xml · nonDerivative · entry 1

COUGHLIN TIMOTHY · CIK 0001376043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022.

F2 · price: RSUs convert into common stock on a one-for-one basis.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 17:08 UTC
Shukla SanjayDirector · President and CEO
GrantEmployee Stock Option (right to buy) · Derivative 336,096 $0.00 Strike: $2.20 $0.00
Disclosure

SEC source: 0001209191-23-011282 · doc4.xml · derivative · entry 1

Shukla Sanjay · CIK 0001671026 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 336,096

Underlying: Common Stock · 336,096 shares

Expires 2033-02-16

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 16, 2023, such that this option will be fully exercisable on February 16, 2027. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 22:04 UTC
Broadfoot Jill MarieChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 84,023 $0.00 Strike: $2.20 $0.00
Disclosure

SEC source: 0001209191-23-011275 · doc4.xml · derivative · entry 1

Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,023

Underlying: Common Stock · 84,023 shares

Expires 2033-02-16

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 16, 2023, such that this option will be fully exercisable on February 16, 2027. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 22:00 UTC
DENYES NANCYGeneral Counsel
GrantEmployee Stock Option (right to buy) · Derivative 84,023 $0.00 Strike: $2.20 $0.00
Disclosure

SEC source: 0001209191-23-011248 · doc4.xml · derivative · entry 1

DENYES NANCY · CIK 0001640869 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,023

Underlying: Common Stock · 84,023 shares

Expires 2033-02-16

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 16, 2023, such that this option will be fully exercisable on February 16, 2027. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.

Read SEC document
February 06, 2023 Filed Feb 7, 2023 00:00 UTC
Broadfoot Jill MarieChief Financial Officer
SaleCommon stock 1,566 $2.36 $3,695.76
Disclosure

SEC source: 0001209191-23-007364 · doc4.xml · nonDerivative · entry 2

Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,460

F4 · kind: Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 3, 2022.

Read SEC document
February 03, 2023 Filed Feb 6, 2023 18:57 UTC
Shukla SanjayDirector · President and CEO
Exercise / conversionRestricted Stock Unit · Derivative 10,375 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-007362 · doc4.xml · derivative · entry 2

Shukla Sanjay · CIK 0001671026 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,125

Underlying: Common Stock · 10,375 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.

F3 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.

Read SEC document
February 03, 2023 Filed Feb 6, 2023 18:57 UTC
Shukla SanjayDirector · President and CEO
Exercise / conversionCommon stock 10,375 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-007362 · doc4.xml · nonDerivative · entry 1

Shukla Sanjay · CIK 0001671026 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,173

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 00:00 UTC
Broadfoot Jill MarieChief Financial Officer
Exercise / conversionRestricted Stock Unit · Derivative 3,750 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-007364 · doc4.xml · derivative · entry 3

Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,250

Underlying: Common Stock · 3,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.

F5 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 00:00 UTC
Broadfoot Jill MarieChief Financial Officer
Exercise / conversionCommon stock 3,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-007364 · doc4.xml · nonDerivative · entry 1

Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,026

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · balance_after: Includes 986 shares acquired under that Company's 2015 Employee Stock Purchase Plan on November 15, 2022.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 00:03 UTC
DENYES NANCYGeneral Counsel
Exercise / conversionRestricted Stock Unit · Derivative 2,688 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-007367 · doc4.xml · derivative · entry 2

DENYES NANCY · CIK 0001640869 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,062

Underlying: Common Stock · 2,688 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.

F4 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 00:03 UTC
DENYES NANCYGeneral Counsel
Exercise / conversionCommon stock 2,688 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-007367 · doc4.xml · nonDerivative · entry 1

DENYES NANCY · CIK 0001640869 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,079

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · balance_after: Includes 944 shares acquired under that Company's 2015 Employee Stock Purchase Plan on November 15, 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.